ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
其他

The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know

Ross A C*; Manson J E; Abrams S A; Aloia J F; Brannon P M; Clinton S K; Durazo Arvizu R A; Gallagher J C; Gallo R L; Jones G; Kovacs C S; Mayne S T; Rosen C J; Shapses S AHarvard Medical School; pennsylvania State University; The Pennsylvania State University; University of California; The Ohio State University; Maine Medical Center Research Institute; Baylor college of medicine; Baylor college of Medicine; Harvard medical school; bpotest; State University of New York at Stony Brook; Rutgers University; Ohio state university; 6; 1; harvard medical school; Creighton University Medical Center; university of california; new; BAYLOR COLLEGE OF MEDICINE; United States
2011DOI: 10.1210/jc.2010-2704
2,556被引5,173阅读
引用收藏
分享

摘要

This article summarizes the new 2011 report on dietary requirements for calcium and vitamin D from the Institute of Medicine (IOM). An IOM Committee charged with determining the population needs for these nutrients in North America conducted a comprehensive review of the evidence for both skeletal and extraskeletal outcomes. The Committee concluded that available scientific evidence supports a key role of calcium and vitamin D in skeletal health, consistent with a cause-and-effect relationship and providing a sound basis for determination of intake requirements. For extraskeletal outcomes, including cancer, cardiovascular disease, diabetes, and autoimmune disorders, the evidence was inconsistent, inconclusive as to causality, and insufficient to inform nutritional requirements. Randomized clinical trial evidence for extraskeletal outcomes was limited and generally uninformative. Based on bone health, Recommended Dietary Allowances (RDAs; covering requirements of ≥97.5% of the population) for calcium range from 700 to 1300 mg/d for life-stage groups at least 1 yr of age. For vitamin D, RDAs of 600 IU/d for ages 1-70 yr and 800 IU/d for ages 71 yr and older, corresponding to a serum 25-hydroxyvitamin D level of at least 20 ng/ml (50 nmol/liter), meet the requirements of at least 97.5% of the population. RDAs for vitamin D were derived based on conditions of minimal sun exposure due to wide variability in vitamin D synthesis from ultraviolet light and the risks of skin cancer. Higher values were not consistently associated with greater benefit, and for some outcomes U-shaped associations were observed, with risks at both low and high levels. The Committee concluded that the prevalence of vitamin D inadequacy in North America has been overestimated. Urgent research and clinical priorities were identified, including reassessment of laboratory ranges for 25-hydroxyvitamin D, to avoid problems of both undertreatment and overtreatment.

基本信息

发表日期
2011
DOI
10.1210/jc.2010-2704

作者

  • R

    Ross A C (通讯) (第一作者)

    pennsylvania state university

  • M

    Manson J E

    brigham and women's hospital

查看全部 14 位作者收起作者
  • A

    Abrams S A

    baylor college of medicine

  • A

    Aloia J F

    state university of new york at stony brook

  • B

    Brannon P M

    united states

  • C

    Clinton S K

    ohio state university

  • D

    Durazo Arvizu R A

    united states

  • G

    Gallagher J C

    creighton university medical center

  • G

    Gallo R L

    university of california · united states

  • J

    Jones G

    6

  • K

    Kovacs C S

    1

  • M

    Mayne S T

    new

  • R

    Rosen C J

    maine medical center research institute

  • S

    Shapses S A

    rutgers · new

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417